Respiratory syncytial virus (RSV)
Find out why Mayo Clinic is the right place for your health care. Make an appointment..
Find a directory of doctors and departments at all Mayo Clinic campuses. Visit now..
See how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now..
Educators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree..
Explore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates..
Your support accelerates powerful innovations in patient care, research and education. Give today..
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It’s so common that most children have been infected with the virus by age 2. Respiratory syncytial (sin-SISH-ul) virus can also infect adults.
In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold. Self-care measures are usually all that’s needed to relieve any discomfort.
RSV can cause severe infection in some people, especially premature babies, older adults, infants and adults with heart and lung disease, or anyone with a very weak immune system (immunocompromised).
Signs and symptoms of respiratory syncytial virus infection most commonly appear about four to six days after exposure to the virus. In adults and older children, RSV usually causes mild cold-like signs and symptoms. These include:
Respiratory syncytial virus infection can spread to the lower respiratory tract, causing pneumonia or bronchiolitis — inflammation of the small airway passages entering the lungs. Signs and symptoms may include:
Infants are most severely affected by RSV. You may notice your child’s chest muscles and skin pull inward with each breath. This is a sign that he or she is struggling to breathe. Other signs and symptoms of severe RSV infection in infants include:
Most children and adults recover in one to two weeks, although some might have repeated wheezing. Severe or life-threatening infection requiring a hospital stay may occur in premature babies or infants and adults who have chronic heart or lung problems.
Seek immediate medical attention if your child — or anyone at risk of severe RSV infection — has difficulty breathing, a high fever, or a blue color to the skin, particularly on the lips and in the nail beds.
Respiratory syncytial virus enters the body through the eyes, nose or mouth. It spreads easily through the air on infected respiratory droplets. You or your child can become infected if someone with RSV coughs or sneezes near you. The virus also passes to others through direct contact, such as shaking hands.
The virus can live for hours on hard objects such as countertops, crib rails and toys. Touch your mouth, nose or eyes after touching a contaminated object and you’re likely to pick up the virus.
An infected person is most contagious in the first few days after infection. However, the virus may continue to spread for up to a few weeks.
By age 2, most children will have been infected with respiratory syncytial virus. Children who attend child care centers or who have siblings who attend school are at a higher risk of exposure. RSV season — when outbreaks tend to occur — is the fall to the end of spring.
People at increased risk of severe or sometimes life-threatening RSV infections include:
Complications of respiratory syncytial virus include:
No vaccine exists for respiratory syncytial virus. But common-sense precautions can help prevent the spread of this infection:
The medication palivizumab (Synagis) can help protect certain children who are at high risk of serious complications of RSV. The medication is recommended for infants under age 1 who were born prematurely (before 29 weeks gestation). It’s not recommended for healthy preemies born after 29 weeks.
The medication is also recommended for the following children:
The medication is given monthly for five months during peak RSV season. It only helps prevent RSV infection. It doesn’t help treat it once symptoms develop.
Scientists are working to find a nasal-spray vaccine to protect against the respiratory syncytial virus.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.
A single copy of these materials may be reprinted for noncommercial personal use only. “Mayo,” “Mayo Clinic,” “MayoClinic.org,” “Mayo Clinic Healthy Living,” and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.
This site complies with the HONcode standard for trustworthy health information:
verify here.
Respiratory syncytial virus (RSV)
Research & References of Respiratory syncytial virus (RSV)|A&C Accounting And Tax Services
Source
0 Comments